BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brubaker PL. Glucagon‐like Peptide‐2 and the Regulation of Intestinal Growth and Function. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1185-210. [DOI: 10.1002/cphy.c170055] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Turner JM, George P, Lansing M, Slim G, Wizzard PR, Nation P, Brubaker PL, Wales PW. In the Short-term, Milk Fat Globule Epidermal Growth Factor-8 Causes Site-specific Intestinal Growth in Resected Piglets. J Pediatr Gastroenterol Nutr 2020;71:543-9. [PMID: 32910624 DOI: 10.1097/MPG.0000000000002818] [Reference Citation Analysis]
2 Markovic MA, Srikrishnaraj A, Tsang D, Brubaker PL. Requirement for the intestinal epithelial insulin-like growth factor-1 receptor in the intestinal responses to glucagon-like peptide-2 and dietary fat. FASEB J 2020;34:6628-40. [PMID: 32212202 DOI: 10.1096/fj.202000169R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Höllwarth ME, Solari V. Nutritional and pharmacological strategy in children with short bowel syndrome. Pediatr Surg Int 2021;37:1-15. [PMID: 33392698 DOI: 10.1007/s00383-020-04781-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cabri W, Cantelmi P, Corbisiero D, Fantoni T, Ferrazzano L, Martelli G, Mattellone A, Tolomelli A. Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives. Front Mol Biosci 2021;8:697586. [PMID: 34195230 DOI: 10.3389/fmolb.2021.697586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Tang Y, Feng M, Zhu X, Long J, Zhou Z, Liu S. WR-GLP2, a glucagon-like peptide 2 from hybrid crucian carp that protects intestinal mucosal barrier and inhibits bacterial infection. Fish & Shellfish Immunology 2022. [DOI: 10.1016/j.fsi.2022.01.035] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gobron B, Bouvard B, Legrand E, Chappard D, Mabilleau G. GLP-2 administration in ovariectomized mice enhances collagen maturity but did not improve bone strength. Bone Rep 2020;12:100251. [PMID: 32071954 DOI: 10.1016/j.bonr.2020.100251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Slim GM, Lansing M, Wizzard P, Nation PN, Wheeler SE, Brubaker PL, Jeppesen PB, Wales PW, Turner JM. Novel Long‐Acting GLP‐2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum. Journal of Parenteral and Enteral Nutrition 2019;43:891-8. [DOI: 10.1002/jpen.1500] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
8 Kappel SS, Sangild PT, Hilsted L, Hartmann B, Thymann T, Aunsholt L. Gastric Residual to Predict Necrotizing Enterocolitis in Preterm Piglets As Models for Infants. JPEN J Parenter Enteral Nutr 2021;45:87-93. [PMID: 32100882 DOI: 10.1002/jpen.1814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Holst JJ, Albrechtsen NJW, Rosenkilde MM, Deacon CF. Physiology of the Incretin Hormones, GIP and GLP ‐1—Regulation of Release and Posttranslational Modifications. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1339-81. [DOI: 10.1002/cphy.c180013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
10 Martchenko SE, Sweeney ME, Dimitriadou V, Murray JA, Brubaker PL. Site-Specific and Temporal Effects of Apraglutide, a Novel Long-Acting Glucagon-Like Peptide-2 Receptor Agonist, on Intestinal Growth in Mice. J Pharmacol Exp Ther 2020;373:347-52. [PMID: 32144124 DOI: 10.1124/jpet.119.263947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Herrnreiter CJ, Li X, Luck ME, Zilliox MJ, Choudhry MA. Integrated analysis of dysregulated microRNA and mRNA expression in intestinal epithelial cells following ethanol intoxication and burn injury. Sci Rep 2021;11:20213. [PMID: 34642361 DOI: 10.1038/s41598-021-99281-1] [Reference Citation Analysis]
12 Núñez-sánchez MA, Herisson FM, Cluzel GL, Caplice NM. Metabolic syndrome and synbiotic targeting of the gut microbiome. Current Opinion in Food Science 2021;41:60-9. [DOI: 10.1016/j.cofs.2021.02.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
13 Chandwe K, Kelly P. Colostrum Therapy for Human Gastrointestinal Health and Disease. Nutrients 2021;13:1956. [PMID: 34200282 DOI: 10.3390/nu13061956] [Reference Citation Analysis]
14 Yusta B, Matthews D, Koehler JA, Pujadas G, Kaur KD, Drucker DJ. Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse. Endocrinology 2019;160:1950-63. [PMID: 31237617 DOI: 10.1210/en.2019-00398] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
15 McCarty MF, Lerner A. Perspective: Prospects for Nutraceutical Support of Intestinal Barrier Function. Adv Nutr 2021;12:316-24. [PMID: 33126251 DOI: 10.1093/advances/nmaa139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
16 Martchenko A, Brubaker PL. Effects of Obesogenic Feeding and Free Fatty Acids on Circadian Secretion of Metabolic Hormones: Implications for the Development of Type 2 Diabetes. Cells 2021;10:2297. [PMID: 34571945 DOI: 10.3390/cells10092297] [Reference Citation Analysis]
17 Fesler Z, Mitova E, Brubaker PL. GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation. Endocrinology 2020;161:bqaa040. [PMID: 32147716 DOI: 10.1210/endocr/bqaa040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Billeschou A, Hunt JE, Ghimire A, Holst JJ, Kissow H. Intestinal Adaptation upon Chemotherapy-Induced Intestinal Injury in Mice Depends on GLP-2 Receptor Activation. Biomedicines 2021;9:46. [PMID: 33430185 DOI: 10.3390/biomedicines9010046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Romaní-Pérez M, López-Almela I, Bullich-Vilarrubias C, Rueda-Ruzafa L, Gómez Del Pulgar EM, Benítez-Páez A, Liebisch G, Lamas JA, Sanz Y. Holdemanella biformis improves glucose tolerance and regulates GLP-1 signaling in obese mice. FASEB J 2021;35:e21734. [PMID: 34143451 DOI: 10.1096/fj.202100126R] [Reference Citation Analysis]
20 Hargrove DM, Alagarsamy S, Croston G, Laporte R, Qi S, Srinivasan K, Sueiras-Diaz J, Wiśniewski K, Hartwig J, Lu M, Posch AP, Wiśniewska H, Schteingart CD, Rivière PJ, Dimitriadou V. Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome. J Pharmacol Exp Ther 2020;373:193-203. [PMID: 32075870 DOI: 10.1124/jpet.119.262238] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
21 Cheng W, Wang K, Zhao Z, Mao Q, Wang G, Li Q, Fu Z, Jiang Z, Wang J, Li J. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment. Theranostics 2020;10:7561-80. [PMID: 32685005 DOI: 10.7150/thno.41802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
22 Aoki K, Suzuki T, Hui F, Nakano T, Yanazawa K, Yonamine M, Fujita S, Sugasawa T, Yoshida Y, Omi N, Kawakami Y, Takekoshi K. Acute Low-Intensity Treadmill Running Upregulates the Expression of Intestinal Glucose Transporters via GLP-2 in Mice. Nutrients 2021;13:1735. [PMID: 34065342 DOI: 10.3390/nu13051735] [Reference Citation Analysis]
23 Mikov M, Pavlović N, Stanimirov B, Đanić M, Goločorbin-Kon S, Stankov K, Al-Salami H. DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment. Eur J Drug Metab Pharmacokinet 2020;45:1-14. [PMID: 31385198 DOI: 10.1007/s13318-019-00570-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wu Y, Xu H, Tu X, Gao Z. The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension. Front Microbiol 2021;12:730809. [PMID: 34650536 DOI: 10.3389/fmicb.2021.730809] [Reference Citation Analysis]
25 Liddle RA. Neuropods. Cell Mol Gastroenterol Hepatol 2019;7:739-47. [PMID: 30710726 DOI: 10.1016/j.jcmgh.2019.01.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
26 Campbell JR, Martchenko A, Sweeney ME, Maalouf MF, Psichas A, Gribble FM, Reimann F, Brubaker PL. Essential Role of Syntaxin-Binding Protein-1 in the Regulation of Glucagon-Like Peptide-1 Secretion. Endocrinology 2020;161:bqaa039. [PMID: 32141504 DOI: 10.1210/endocr/bqaa039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
27 Moran AW, Al-Rammahi MA, Daly K, Grand E, Ionescu C, Bravo DM, Wall EH, Shirazi-Beechey SP. Consumption of a Natural High-Intensity Sweetener Enhances Activity and Expression of Rabbit Intestinal Na+/Glucose Cotransporter 1 (SGLT1) and Improves Colibacillosis-Induced Enteric Disorders. J Agric Food Chem 2020;68:441-50. [PMID: 31736308 DOI: 10.1021/acs.jafc.9b04995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Fortea M, Albert-Bayo M, Abril-Gil M, Ganda Mall JP, Serra-Ruiz X, Henao-Paez A, Expósito E, González-Castro AM, Guagnozzi D, Lobo B, Alonso-Cotoner C, Santos J. Present and Future Therapeutic Approaches to Barrier Dysfunction. Front Nutr 2021;8:718093. [PMID: 34778332 DOI: 10.3389/fnut.2021.718093] [Reference Citation Analysis]
29 Stemmer K, Finan B, DiMarchi RD, Tschöp MH, Müller TD. Insights into incretin-based therapies for treatment of diabetic dyslipidemia. Adv Drug Deliv Rev 2020;159:34-53. [PMID: 32485206 DOI: 10.1016/j.addr.2020.05.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
30 Honig G, Larkin PB, Heller C, Hurtado-Lorenzo A. Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021;27:S1-S16. [PMID: 34791292 DOI: 10.1093/ibd/izab230] [Reference Citation Analysis]
31 Conlon JM. The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective. Front Endocrinol (Lausanne) 2021;12:683089. [PMID: 34177808 DOI: 10.3389/fendo.2021.683089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Le Beyec-le Bihan J, Ledoux S, Coëffier M, Le Gall M. L’intestin un organe endocrine : de la physiologie aux implications thérapeutiques en nutrition. Nutrition Clinique et Métabolisme 2022;36:75-88. [DOI: 10.1016/j.nupar.2021.12.179] [Reference Citation Analysis]
33 Lerner A, McCarty MF. The Aging Bowel Dysfunction and Elderly Vulnerability towards COVID-19 Infection. Life (Basel) 2021;11:97. [PMID: 33525368 DOI: 10.3390/life11020097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Borghini R, Caronna R, Donato G, Picarelli A. GLP-2 analog Teduglutide in active Crohn's disease and short bowel syndrome: Confirmation of anti-inflammatory role and future perspectives. Dig Liver Dis 2020;52:686-7. [PMID: 32340888 DOI: 10.1016/j.dld.2020.03.019] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Chang Y, Deng Q, Zhang Z, Zhao H, Tang J, Chen X, Liu G, Tian G, Cai J, Jia G. Glucagon-like peptide 2 attenuates intestinal mucosal barrier injury through the MLCK/pMLC signaling pathway in a piglet model. J Cell Physiol 2021;236:3015-32. [PMID: 32960454 DOI: 10.1002/jcp.30068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Cremonini E, Daveri E, Mastaloudis A, Oteiza PI. (-)-Epicatechin and Anthocyanins Modulate GLP-1 Metabolism: Evidence from C57BL/6J Mice and GLUTag Cells. J Nutr 2021;151:1497-506. [PMID: 33693759 DOI: 10.1093/jn/nxab029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Martchenko SE, Prescott D, Martchenko A, Sweeney ME, Philpott DJ, Brubaker PL. Diurnal changes in the murine small intestine are disrupted by obesogenic Western Diet feeding and microbial dysbiosis. Sci Rep 2021;11:20571. [PMID: 34663882 DOI: 10.1038/s41598-021-98986-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Markovic MA, Brubaker PL. The roles of glucagon-like peptide-2 and the intestinal epithelial insulin-like growth factor-1 receptor in regulating microvillus length. Sci Rep 2019;9:13010. [PMID: 31506583 DOI: 10.1038/s41598-019-49510-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
39 Davis EM, Sandoval DA. Glucagon‐Like Peptide‐1: Actions and Influence on Pancreatic Hormone Function. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 577-95. [DOI: 10.1002/cphy.c190025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
40 Irwin DM. Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals. Front Endocrinol (Lausanne) 2021;12:700066. [PMID: 34322093 DOI: 10.3389/fendo.2021.700066] [Reference Citation Analysis]
41 Zambrana LE, Weber AM, Borresen EC, Zarei I, Perez J, Perez C, Rodríguez I, Becker-Dreps S, Yuan L, Vilchez S, Ryan EP. Daily Rice Bran Consumption for 6 Months Influences Serum Glucagon-Like Peptide 2 and Metabolite Profiles without Differences in Trace Elements and Heavy Metals in Weaning Nicaraguan Infants at 12 Months of Age. Curr Dev Nutr 2021;5:nzab101. [PMID: 34514286 DOI: 10.1093/cdn/nzab101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Holst JJ, Andersen DB, Grunddal KV. Actions of glucagon-like peptide-1 receptor ligands in the gut. Br J Pharmacol 2021. [PMID: 34235727 DOI: 10.1111/bph.15611] [Reference Citation Analysis]
43 Deng G, Lei Q, Gao X, Zhang Y, Zheng H, Bi J, Wang X. Glucagon-Like Peptide-2 Modulates Enteric Paneth Cells Immune Response and Alleviates Gut Inflammation During Intravenous Fluid Infusion in Mice With a Central Catheter. Front Nutr 2021;8:688715. [PMID: 34540875 DOI: 10.3389/fnut.2021.688715] [Reference Citation Analysis]